Baxdrostat
CAS 1428652-17-8Small Molecule
Overview
Baxdrostat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4113975).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Baxdrostat expires 4 Feb 2033 and exclusivity 15 May 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(8R)-4-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide
- Canonical SMILES
- CCC(=O)N[C@@H]1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C
- InChIKey
- VDEUDSRUMNAXJG-LJQANCHMSA-N
Verified Supplier Partner
Do you supply Baxdrostat? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.